Jamie Dimon’s succession delay has turned JPMorgan into a CEO recruiting gold mine.
AI has quickly become embedded in our everyday work, from drafting emails to synthesizing research and making decisions. In my roles as a medical doctor and business consultant, I talk to many corporate leaders who are focused on what that means for p…
China’s LineShine debuted as the world’s fastest supercomputer on TOP500, but mixed-precision benchmark results complicate its AI performance claim.
The post China’s LineShine Tops Supercomputer List Despite AI Benchmark Gap appeared first on TechRepub…
Still waiting for the procurement reform Ottawa promised via the newly established Defence Investment Agency
In October 1956, when Soviet tanks rolled into Budapest to crush the nascent Hungarian Revolution and the national aspirations it represented, the communist empire seemed at its apex. With a strong leader, a command economy, and an iron will, it seeme…
Global steel investment is flat, but DRI-EAF production is gaining share in advanced economies.
The continued rise of monoclonal antibody therapies and demographic changes are powering growth in the pharmaceuticals industry.
Manufacturing polyethylene is a highly competitive business. Success depends greatly on access to feedstocks, yet investment doesn’t always follow economics.
Innovation after innovation is advancing the biopharmaceutical industry, enabling better treatment of complex diseases. The industry has historically made its home in Europe and the United States, but that’s changing.
Data center capital expenditures are surging as AI workloads grow, yet competitiveness increasingly depends on securing advanced accelerators, reliable electricity, and fast project delivery.
